Carcinotech: A New, Exciting Biotech Client for Haggarty-Weir Consulting.

Brendan Copp and Dr. Christopher Haggarty-Weir recently engaged with and completed some web-development and marketing report work for their client Carcinotech. Carcinotech is an exciting new Edinburgh-based biotech start-up with a focus on microfluidics applied to cancer and stem cells. More specifically, the technology being developed is aimed at replicating cellular cancer environments on a micro-sized chip in order to aid research efforts, hopefully eliminate pre-clinical animal testing, and contribute to the personalized medicine paradigm. Founder and Director of Carcinotech, Ishani Malhotra, set up the company in mid-2018 and has received funding and recognition from the Scottish Institute for Enterprise (winning the Fresh Ideas Competition last November) and Santander. Additionally, Ms. Malhotra has been shortlisted for phase 2 of the Converge Kickstart Challenge.

The aforementioned team at Haggarty-Weir Consulting was engaged by Carcinotech to develop their website (as seen here), and to put together a short-term marketing strategy report to aid Ms. Malhotra’s efforts in growing her nascent company. Ms. Malhotra said of the services provided ‘Despite providing very basic information for what I wanted, the website was developed in a clean and professional manner, within budget, and ahead of schedule. I think the interactions and service was great!’. Dr. Haggarty-Weir has also signed a confidential non-disclosure agreement (NDA) with Carcinotech and says ‘By signing the NDA I am able to further understand the technology being developed and patented by Carcinotech. I look forwards to my firm being able to provide even more services to Ms. Malhotra in 2019’.

If your company requires web development services or strategic insight, then please get in touch with us at dr.chris@haggarty-weirconsulting.com.